Medicine by Design-funded foundational technology grows into biotech success story: Notch Therapeutics closes an $85 million Series A financing

Medicine by Design-funded research program that aims to generate next-generation immunomodulation therapies has seeded a Canadian biotechnology success story with the closing of an $85-million (U.S.) Series A financing.

By |2021-02-11T16:40:53-05:00February 10th, 2021|Categories: News|Tags: , , , , |

Medicine by Design announces four new team projects

Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.

By |2020-03-04T08:52:07-05:00February 28th, 2020|Categories: Awards, News, Team Projects|Tags: , , , , |
Go to Top